NCT01926158View on ClinicalTrials.gov

Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 4, 2017

Study Completion Date

December 31, 2017

Conditions
Hip Osteoarthritis
Interventions
DRUG

Denosumb

Prefilled syringe of 1 mL denosumab solution

DRUG

Placebo (for denosumab)

Trial Locations (1)

20521

Turku University Hospital, Turku

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Turku University Hospital

OTHER_GOV

NCT01926158 - Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women | Biotech Hunter | Biotech Hunter